You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
微芯生物(688321.SH):已開展DeepSeek本地化部署
格隆匯 03-11 16:36

格隆匯3月11日丨微芯生物(688321.SH)在互動平台表示,公司目前使用華為盤古大模型實現輔助藥物分子設計。公司在成立之初即關注新技術在原創新藥領域的應用,“微芯(chipscreen)”正體現了公司微陣列基因芯片平台用於藥物開發的這一重要技術特徵。公司自主開發的藥物開發平台通過深刻理解疾病-基因-藥物三者的關係,加速靶點發現、藥物篩選。而自2022年開始與華為雲的合作,有效補足了蛋白質-藥物相互作用等部分,為微芯生物原創新藥全鏈條獨立、自主開發的閉環提供極大幫助。2025年,中國首個“AI+藥械專業委員會”於河套深港科技創新合作區正式揭牌成立,公司董事長兼總經理魯先平博士受聘為專委會副主任委員。此外,目前公司已開展DeepSeek本地化部署。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account